REILLY FINANCIAL ADVISORS, LLC - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 392 filers reported holding SEATTLE GENETICS INC in Q1 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
REILLY FINANCIAL ADVISORS, LLC ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$78,000
+52.9%
400
+33.3%
0.01%
+33.3%
Q2 2020$51,000
+45.7%
3000.0%0.01%
+20.0%
Q1 2020$35,000
+2.9%
3000.0%0.01%
+25.0%
Q4 2019$34,000
+30.8%
3000.0%0.00%
+33.3%
Q3 2019$26,000
+23.8%
3000.0%0.00%0.0%
Q2 2019$21,000
-4.5%
3000.0%0.00%0.0%
Q1 2019$22,000
+29.4%
3000.0%0.00%
+50.0%
Q4 2018$17,000
-26.1%
3000.0%0.00%
-33.3%
Q3 2018$23,000
+15.0%
3000.0%0.00%0.0%
Q2 2018$20,0003000.00%
Other shareholders
SEATTLE GENETICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Parametrica Management Ltd 3,581$248,00042.18%
Baker Brothers Advisors 50,057,277$3,464,464,00023.54%
Lagoda Investment Management, L.P. 76,073$5,265,0006.10%
Matrix Capital Management Company, LP 3,141,852$217,448,0004.02%
DOMINI IMPACT INVESTMENTS LLC 3,111$215,0002.98%
Opus Point Partners Management, LLC 17,901$1,239,0001.83%
EMORY UNIVERSITY 33,593$2,325,0001.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 60,900$4,215,0001.56%
Capital International Sarl 130,400$9,025,0001.26%
CAPITAL GUARDIAN TRUST CO 1,303,961$90,147,0001.21%
View complete list of SEATTLE GENETICS INC shareholders